Headshot of Brian Albarran
Area of Focus
Oncology Targeted Protein Degradation
Publish Date
April 21, 2023
Brian Albarran, PhD, Senior Vice President, Head of Corporate Strategy

Small Molecules, Big Impact: Expanding the Universe of Targets

Targeted protein degradation (TPD), at a very high level, is a compelling, novel modality: You can use small molecules to eradicate intractable proteins that aren’t able to be addressed or are poorly addressed by other modalities, delivering a potentially transformative new way to fight disease.